Richard Huhn, MD is consulting to HiberCell as Senior Medical Director. Prior to this role, Dr. Huhn was Senior Medical Director at Ambrx, Boehringer Ingelheim and Biothera, directing development of antineoplastic biological agents. Dr. Huhn was formally trained in Hematology (focus on cellular and gene therapies) at the US National Institutes of Health and previously in Clinical Pharmacology in the Brown University medical program. He has held positions as Medical Director of the NJ Cord Blood Bank and stem cell research program at the Coriell Institute, and as Medical Reviewer in the Office of Cellular, Tissue and Gene Therapy at the US Food and Drug Administration, as well as various roles in basic and clinical Oncology and Hematology research programs in academia and pharma/biotechnology programs.